Rebecca Martin is a Scientific Consultant at GLG, leveraging over a decade of experience in the Biotech Pharma sector to provide insights for clients navigating scientific markets. Prior roles include Principal Scientist and Senior Scientist at Molecular Templates, focusing on preclinical pharmacology and in vitro pharmacology, where Rebecca specialized in cellular assay techniques and led external collaborations to advance oncology drugs. Previously, as a Scientist at XBiotech USA, Rebecca developed and qualified assays to evaluate therapeutic drug candidates and isolated high-affinity antibodies through phage display techniques. Education includes a Master's in Molecular Biology and a Bachelor's degree in Biology from The University of Texas Permian Basin.